Insertion/deletion mutations within tva receptor gene confer chicken resistance to infection by avian leukosis virus subgroups A and K

tva受体基因内的插入/缺失突变赋予鸡对禽白血病病毒A亚群和K亚群感染的抵抗力。

阅读:3
作者:Huijuan Xu,Kejing Zuo,Zhixiang Kuang,Sheng Chen,Xuefeng Zhu,Huanmin Zhang,Qingmei Xie,Weiguo Chen

Abstract

The classic subgroup A (ALV-A) and newly emerging subgroup K (ALV-K) of avian leukosis virus are two major pathogens responsible for avian leukemia in chickens, posing substantial threats to global poultry industry. Both viruses share a Tva protein encoded by the tva gene as a receptor to gain the entry into the host cells. In this study, we described the identifications of two alleles of the tva receptor gene in Qingyuan partridge chicken, which possesses an 11-nucleotide (GCTGCCCACCC) insertion and a 6-nucleotide (ACCTCC) deletion independently located in exon 1 of the tva receptor gene. The natural 11-nucleotide insertion causes a frameshift in the reading frame of the tva cDNA, which presumably blocks the expression of the normal tva allele and results resistance in chicken against infection by ALV-A and ALV-K. The natural 6-nucleotide deletion leads to a Tva receptor protein missing the amino acids residues T21 and S22, which appeared dysfunctional to mediate the viral entry. As a result, we observed that the deletion mutation in the tva receptor gene significantly reduced the susceptibility to infection by ALV-A and ALV-K in vitro and in vivo, and significantly reduced the binding capacity of the Tva receptor protein to the envelope glycoproteins of ALV-A and ALV-K in our subsequent analysis. Taken together, these findings not only provide evidence that the insertion and deletion mutations within the tva receptor gene confer chicken resistance to infection by ALV-A and ALV-K but also provide ideal targets for selective breeding of ALV-A and ALV-K resistance in chicken.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。